Cover Image
市場調查報告書

藥物研發資訊學的全球市場 - 至2022年的預測:定序、目標數據分析,對接,分子模擬,程式庫、資料庫準備

Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, CRO) - Global Forecast to 2022

出版商 MarketsandMarkets 商品編碼 599148
出版日期 內容資訊 英文 117 Pages
訂單完成後即時交付
價格
Back to Top
藥物研發資訊學的全球市場 - 至2022年的預測:定序、目標數據分析,對接,分子模擬,程式庫、資料庫準備 Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Molecular Docking, Library Preparation), Solution (Software, Services), End User (Pharmaceutical & Biotechnology, CRO) - Global Forecast to 2022
出版日期: 2017年12月18日 內容資訊: 英文 117 Pages
簡介

全球藥物研發資訊學市場,預計從2017年的16億7000萬美元,到2022年擴大到28億4000萬美元。預計市場2017年∼2022年以11.2%的年複合成長率成長。

本報告提供全球藥物研發資訊學市場相關調查分析,市場概要,產業趨勢,各市場區隔的市場分析,競爭情形,主要企業等相關的系統性資訊。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 藥物研發資訊學:市場概要
  • 亞太地區的藥物研發資訊學市場:各功能,各終端用戶
  • 藥物研發資訊學市場:各解決方案
  • 藥物研發資訊學市場各地區概述

第5章 市場概要

  • 簡介
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 機會
    • 課題

第6章 藥物研發資訊學的全球市場:各功能

  • 簡介
  • 定序、目標數據分析
  • 對接
  • 分子模擬
  • 程式庫、資料庫準備
  • 其他

第7章 藥物研發資訊學的全球市場:各解決方案

  • 簡介
  • 軟體
  • 服務

第8章 藥物研發資訊學的全球市場:各終端用戶

  • 簡介
  • 製藥、生物科技企業
  • CRO
  • 其他

第9章 藥物研發資訊學的全球市場:各地區

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第10章 競爭情形

  • 簡介
  • 企業的排行榜
  • 競爭模式

第11章 企業簡介

  • JUBILANT LIFE SCIENCES
  • IBM
  • INFOSYS
  • THERMO FISHER SCIENTIFIC
  • PERKINELMER
  • SCHRODINGER
  • DASSAULT SYSTEMES
  • CHARLES RIVER LABORATORIES
  • SELVITA
  • CERTARA
  • GVK BIOSCIENCES
  • COLLABORATIVE DRUG DISCOVERY
  • OPENEYE SCIENTIFIC SOFTWARE
  • IO INFORMATICS
  • NOVO INFORMATICS

第12章 附錄

目錄
Product Code: HIT 5838

"The global drug discovery informatics market is projected to grow at a CAGR of 11.2%."

The global drug discovery informatics market is expected to reach USD 2.84 billion in 2022 from USD 1.67 billion in 2017 at a CAGR of 11.2%. Growth in the drug discovery informatics market is mainly driven by factors such as rising R&D expenditure across the globe, increasing focus on drug delivery, and the need to control drug discovery and development costs. Impending patent expiries and the growing biotechnology industry are also expected to provide a wide range of growth opportunities for players in the market. On the other hand, the scarcity of skilled professionals and the high pricing and setup cost of informatics software are both factors that are expected to limit market growth to a certain extent.

"The sequencing and target data analysis segment is expected to account for the largest share in 2017."

On the basis of function, the drug discovery informatics market is divided into sequencing and target data analysis, docking, molecular modeling, libraries & database preparation, and other functions. In 2017, the sequencing and target data analysis segment is expected to account for the largest share of the drug discovery informatics market. Factors such as the expansive application of informatics solutions in targeted analysis and the large amount of data generated during the drug discovery process are driving the growth of this segment.

"The software segment is expected to account for the largest share in 2017."

On the basis of solution, the market is classified into software and services. In 2017, the software segment is expected to account for the largest share of the global drug discovery informatics market. The largest share of this segment is attributed to the fast and efficient management of data generated throughout the drug discovery process using discovery informatics software solutions.

"North America is expected to account for the largest share during the forecast period."

By geography, North America is expected to account for the largest share of the drug discovery informatics market in 2017. Established pharmaceutical industry with the presence of leading pharmaceutical and biotechnology companies attributes to the largest share of North America. Europe is expected to account for the second-largest share of the drug discovery informatics market.

Break-up Profile of Primaries:

  • By Company Type- Tier 1-45%, Tier 2-34% and Tier 3-21%
  • By Designation-C-level-36%, D-level-40% and Others-24%
  • By Region-North America-40%, Europe-22%, Asia Pacific-30%, and RoW-8%

The key players operating in the drug discovery informatics market are IBM (US), Infosys (India), Schrodinger (US), PerkinElmer (US), and Thermo Fisher Scientific (US).

Research Coverage:

The drug discovery informatics market in this report is segmented by function, solution, end user, and region. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions, and profiles key players and core competencies in the drug discovery informatics market.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on portfolios offered by the top players in the global drug discovery informatics market. The report analyzes the market by function, solution, end user, and region
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global drug discovery informatics market
  • Market Development: Comprehensive information about lucrative emerging markets-the report analyzes the markets for global discovery informatics products across regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the global drug discovery informatics market
  • Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global drug discovery informatics market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
      • 2.1.2.2. Key industry insights
  • 2.2. MARKET SIZE ESTIMATION
  • 2.3. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.4. ASSUMPTIONS

3. EXECUTIVE SUMMARY

4. PREMIUM INSIGHTS

  • 4.1. DRUG DISCOVERY INFORMATICS: MARKET OVERVIEW
  • 4.2. ASIA PACIFIC DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION AND END USER
  • 4.3. DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION
  • 4.4. GEOGRAPHICAL SNAPSHOT OF THE DRUG DISCOVERY INFORMATICS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET DYNAMICS
    • 5.2.1. DRIVERS
      • 5.2.1.1. Rising R&D expenditure
      • 5.2.1.2. Increasing focus on drug discovery
      • 5.2.1.3. Need to control drug discovery and development costs
    • 5.2.2. RESTRAINT
      • 5.2.2.1. High pricing and setup cost of informatics software
    • 5.2.3. OPPORTUNITIES
      • 5.2.3.1. Patent expiry
      • 5.2.3.2. Growing biotechnology industry
    • 5.2.4. CHALLENGE
      • 5.2.4.1. Scarcity of skilled professionals

6. DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION

  • 6.1. INTRODUCTION
  • 6.2. SEQUENCING & TARGET DATA ANALYSIS
  • 6.3. DOCKING
  • 6.4. MOLECULAR MODELLING
  • 6.5. LIBRARIES & DATABASE PREPARATION
  • 6.6. OTHER FUNCTIONS

7. DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION

  • 7.1. INTRODUCTION
  • 7.2. SOFTWARE
  • 7.3. SERVICES

8. DRUG DISCOVERY INFORMATICS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
  • 8.3. CONTRACT RESEARCH ORGANIZATIONS (CROS)
  • 8.4. OTHER END USERS

9. DRUG DISCOVERY INFORMATICS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. US
    • 9.2.2. CANADA
  • 9.3. EUROPE
    • 9.3.1. GERMANY
    • 9.3.2. REST OF EUROPE
  • 9.4. ASIA PACIFIC (APAC)
  • 9.5. REST OF THE WORLD

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. RANKING OF PLAYERS, 2016
  • 10.3. COMPETITIVE SCENARIO
    • 10.3.1. COLLABORATIONS, PARTNERSHIPS, AGREEMENTS, & ACQUISITIONS
    • 10.3.2. EXPANSIONS
    • 10.3.3. PRODUCT LAUNCHES & ENHANCEMENTS

11. COMPANY PROFILES (Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, Recent Developments)*

  • 11.1. JUBILANT LIFE SCIENCES
  • 11.2. IBM
  • 11.3. INFOSYS
  • 11.4. THERMO FISHER SCIENTIFIC
  • 11.5. PERKINELMER
  • 11.6. SCHRODINGER
  • 11.7. DASSAULT SYSTEMES
  • 11.8. CHARLES RIVER LABORATORIES
  • 11.9. SELVITA
  • 11.10. CERTARA
  • 11.11. GVK BIOSCIENCES
  • 11.12. COLLABORATIVE DRUG DISCOVERY
  • 11.13. OPENEYE SCIENTIFIC SOFTWARE
  • 11.14. IO INFORMATICS
  • 11.15. NOVO INFORMATICS

*Details on MarketsandMarkets view, Overview, Products Offered, Product Offering Scorecard, Business Strategy Scorecard, and Recent Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. INSIGHTS OF INDUSTRY EXPERTS
  • 12.2. DISCUSSION GUIDE
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS
  • 12.7. AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 2: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 3: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 4: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SEQUENCING & TARGET DATA ANALYSIS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 5: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 6: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 7: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR DOCKING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 8: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 9: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 10: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR MOLECULAR MODELLING, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 11: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARIES & DATABASE PREPARATION, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 12: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARIES & DATABASE PREPARATION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 13: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR LIBRARIES & DATABASE PREPARATION, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 14: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 15: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 16: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER FUNCTIONS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 17: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 18: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 19: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 20: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SOFTWARE, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 21: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 22: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 23: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR SERVICES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 24: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 25: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 26: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 27: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 28: DRUG DISCOVERY INFORMATICS MARKET FOR CROS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 29: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR CROS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 30: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR CROS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 31: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 32: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 33: EUROPE: DRUG DISCOVERY INFORMATICS MARKET FOR OTHER END USERS, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 34: DRUG DISCOVERY INFORMATICS MARKET, BY REGION, 2015-2022 (USD MILLION)
  • TABLE 35: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 36: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 37: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 38: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 39: US: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 40: US: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 41: US: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 42: CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 43: CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 44: CANADA: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 45: EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • TABLE 46: EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 47: EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 48: EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 49: GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 50: GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 51: GERMANY: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 52: REST OF EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 53: REST OF EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 54: REST OF EUROPE: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 56: ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 57: ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 58: ROW: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2015-2022 (USD MILLION)
  • TABLE 59: ROW: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2015-2022 (USD MILLION)
  • TABLE 60: ROW: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2015-2022 (USD MILLION)
  • TABLE 61: COLLABORATIONS, PARTNERSHIPS, AGREEMENTS, & ACQUISITIONS, 2015-2017
  • TABLE 62: EXPANSIONS, 2015-2017
  • TABLE 63: PRODUCT LAUNCHES & ENHANCEMENTS, 2015-2017

LIST OF FIGURES

  • FIGURE 2: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3: BOTTOM UP APPROACH
  • FIGURE 4: TOP DOWN APPROACH
  • FIGURE 6: DRUG DISCOVERY INFORMATICS MARKET, BY FUNCTION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 7: DRUG DISCOVERY INFORMATICS MARKET, BY SOLUTION, 2017 VS. 2022 (USD BILLION)
  • FIGURE 8: DRUG DISCOVERY INFORMATICS MARKET, BY END USER, 2017 VS. 2022 (USD BILLION)
  • FIGURE 9: GEOGRAPHICAL SNAPSHOT OF DRUG DISCOVERY INFORMATICS MARKET (2017-2022)
  • FIGURE 1: RISING FOCUS ON REDUCING OPERATIONAL COSTS-A PRIMARY GROWTH DRIVER OF THE DRUG DISCOVERY INFORMATICS MARKET
  • FIGURE 11: SOFTWARE SEGMENT WILL CONTINUE TO DOMINATE THE DRUG DISCOVERY INFORMATICS MARKET IN 2022
  • FIGURE 12: APAC WILL BE THE FASTEST-GROWING MARKET FROM 2017 TO 2022
  • FIGURE 13: DRUG DISCOVERY INFORMATICS MARKET: DRIVERS, RESTRAINTS, & OPPORTUNITIES
  • FIGURE 14: GLOBAL PHARMACEUTICAL R&D SPENDING, 2012-2022 (USD BILLION)
  • FIGURE 15: DRUG DISCOVERY INFORMATICS FUNCTION
  • FIGURE 16: NORTH AMERICA: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT
  • FIGURE 17: ASIA PACIFIC: DRUG DISCOVERY INFORMATICS MARKET SNAPSHOT
  • FIGURE 18: COMPANIES ADOPTED PRODUCT LAUNCHES, EXPANSIONS, COLLABORATIONS, PARTNERSHIPS, AGREEMENTS, AND ACQUISITIONS AS THEIR KEY GROWTH STRATEGY BETWEEN 2014-2017
  • FIGURE 19: JUBILANT LIFE SCIENCES: COMPANY SNAPSHOT (2017)
  • FIGURE 20: IBM: COMPANY SNAPSHOT (2016)
  • FIGURE 21: INFOSYS: COMPANY SNAPSHOT (2016)
  • FIGURE 22: THERMO FISHER: COMPANY SNAPSHOT (2016)
  • FIGURE 23: PERKINELMER: COMPANY SNAPSHOT (2016)
  • FIGURE 24: DASSAULT SYSTEMES: COMPANY SNAPSHOT (2016)
  • FIGURE 25: CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2016)
  • FIGURE 26: SELVITA: COMPANY SNAPSHOT (2016)
Back to Top